Determination of immunity to vaccinia virus by using diluted inactivated vaccinia vaccine solution for skin testingSOMEKH, Eli; SMETANA, Zahava; TANAY, Amir et al.Vaccine. 2004, Vol 23, Num 3, pp 321-324, issn 0264-410X, 4 p.Article

Engineering recombinant poxviruses using a compact GFP-blasticidin resistance fusion gene for selectionYIK CHUN WONG; LIN, Leon C. W; MELO-SILVA, Carolina R et al.Journal of virological methods. 2011, Vol 171, Num 1, pp 295-298, issn 0166-0934, 4 p.Article

Laboratory-acquired vaccinia infectionWLODAVER, Clifford G; PALUMBO, Gregory J; WANER, Joseph L et al.Journal of clinical virology. 2004, Vol 29, Num 3, pp 167-170, issn 1386-6532, 4 p.Article

Harnessing the unique local immunostimulatory properties of modified vaccinia Ankara (MVA) virus to generate superior tumor-specific immune responses and antitumor activity in a diversified prime and boost vaccine regimenHODGE, James W; HIGGINS, Jack; SCHLOM, Jeffrey et al.Vaccine. 2009, Vol 27, Num 33, pp 4475-4482, issn 0264-410X, 8 p.Article

Rapid generation of markerless recombinant MVA vaccines by en passant recombineering of a self-excising bacterial artificial chromosomeCOTTINGHAM, Matthew G; GILBERT, Sarah C.Journal of virological methods. 2010, Vol 168, Num 1-2, pp 233-236, issn 0166-0934, 4 p.Article

Safety of modified vaccinia virus Ankara (MVA) in immune-suppressed macaquesSTITTELAAR, Koert J; KUIKEN, Thijs; OSTERHAUS, Albert D. M. E et al.Vaccine. 2001, Vol 19, Num 27, pp 3700-3709, issn 0264-410XArticle

Neutralizing antibodies associated with exposure factors to Orthopoxvirus in laboratory workersCOSTA, Galileu Barbosa; MORENO, Elizabeth Castro; DE SOUZA TRINDADE, Giliane et al.Vaccine. 2013, Vol 31, Num 42, pp 4706-4709, issn 0264-410X, 4 p.Article

Sub-viral imaging of vaccinia virus using super-resolution microscopyHORSINGTON, Jacquelyn; TURNBULL, Lynne; WHITCHURCH, Cynthia B et al.Journal of virological methods. 2012, Vol 186, Num 1-2, pp 132-136, issn 0166-0934, 5 p.Article

The Myristate Moiety and Amino Terminus of Vaccinia Virus L1 Constitute a Bipartite Functional Region Needed for EntryCHWAN HONG FOO; WHITBECK, J. Charles; PONCE-DE-LEON, Manuel et al.Journal of virology. 2012, Vol 86, Num 10, pp 5437-5451, issn 0022-538X, 15 p.Article

Molecular Characterization of the Host Defense Activity of the Barrier to Autointegration Factor against Vaccinia VirusIBRAHIM, Nouhou; WICKLUND, April; WIEBE, Matthew S et al.Journal of virology. 2011, Vol 85, Num 22, pp 11588-11600, issn 0022-538X, 13 p.Article

Increased susceptibility of Cantagalo virus to the antiviral effect of ST-246SANTOS-FERNANDES, Elida; BELTRAME, Cristiana O; BYRD, Chelsea M et al.Antiviral research. 2013, Vol 97, Num 3, pp 301-311, issn 0166-3542, 11 p.Article

Reflections on the early development of poxvirus vectorsMOSS, Bernard.Vaccine. 2013, Vol 31, Num 39, pp 4220-4222, issn 0264-410X, 3 p.Article

Le virus de la vaccine, un virus qui se propage plus vite qu'il ne se réplique = Vaccinia virus: a mechanism for rapid virus spreadDOCEUL, Virginie; HOLLINSHEAD, Michael; SMITH, Geoffrey L et al.Virologie (Montrouge). 2012, Vol 16, Num 2, pp 119-121, issn 1267-8694, 3 p.Article

The Vaccinia Virus-Encoded Bcl-2 Homologues Do Not Act as Direct Bax InhibitorsPOSTIGO, Antonio; WAY, Michael.Journal of virology. 2012, Vol 86, Num 1, pp 203-213, issn 0022-538X, 11 p.Article

Characterization of a Newly Identified 35-Amino-Acid Component of the Vaccinia Virus Entry/Fusion Complex Conserved in All ChordopoxvirusesSATHESHKUMAR, P. S; MOSS, Bernard.Journal of virology. 2009, Vol 83, Num 24, pp 12822-12832, issn 0022-538X, 11 p.Article

The attenuation of vaccinia Tian Tan strain by the removal of the viral M1L-K2L genesWEIJUN ZHU; QING FANG; KE ZHUANG et al.Journal of virological methods. 2007, Vol 144, Num 1-2, pp 17-26, issn 0166-0934, 10 p.Article

An alternative genetic method to test essential vaccinia virus early genesKATO, Sayuri E. M; GRECO, Frederico A. B; DAMASO, Clarissa R. A et al.Journal of virological methods. 2004, Vol 115, Num 1, pp 31-40, issn 0166-0934, 10 p.Article

Vaccinia virus lacking A17 induces complex membrane structures composed of open membrane sheetsCHLANDA, Petr; CARBAJAL, Maria Alejandra; KOLOVOU, Androniki et al.Archives of virology. 2011, Vol 156, Num 9, pp 1647-1653, issn 0304-8608, 7 p.Article

Pathogenicity and immunogenicity in mice of vaccinia viruses mutated in the viral envelope proteins A33R and B5RGURT, Irina; ABDALRHMAN, Ihab; KATZ, Ehud et al.Antiviral research. 2006, Vol 69, Num 3, pp 158-164, issn 0166-3542, 7 p.Article

Protection induced in mice against a lethal orthopox virus by the Lister strain of vaccinia virus and modified vaccinia virus Ankara (MVA)ABDALRHMAN, Ihab; GURT, Irina; KATZ, Ehud et al.Vaccine. 2006, Vol 24, Num 19, pp 4152-4160, issn 0264-410X, 9 p.Article

Vaccinia virus infection and gene transduction in cultured neuronsALLEN, Gregory A; DENES, Bela; FODOR, Istvan et al.Microbes and infection. 2005, Vol 7, Num 9-10, pp 1087-1096, issn 1286-4579, 10 p.Article

A rapid detection method for Vaccinia virus, the surrogate for smallpox virusDONALDSON, Kim A; KRAMER, Marianne F; LIM, Daniel V et al.Biosensors & bioelectronics. 2004, Vol 20, Num 2, pp 322-327, issn 0956-5663, 6 p.Article

Environmental persistence of vaccinia virus on materialsWOOD, J. P; CHOI, Y. W; WENDLING, M. Q et al.Letters in applied microbiology. 2013, Vol 57, Num 5, pp 399-404, issn 0266-8254, 6 p.Article

Transient dominant selection of recombinant vaccinia virusesFALKNER, F. G; MOSS, B.Journal of virology. 1990, Vol 64, Num 6, pp 3108-3111, issn 0022-538X, 4 p.Article

The heterogeneity of human antibody responses to vaccinia virus revealed through use of focused protein arraysDUKE-COHAN, Jonathan S; WOLLENICK, Kristin; WITTEN, Elizabeth A et al.Vaccine. 2009, Vol 27, Num 8, pp 1154-1165, issn 0264-410X, 12 p.Article